Cite Filings / REVB
Feed Companies Filings Check
Sign in

CIK 0001810560 · Non-accelerated filer<br>Smaller reporting company

REVELATION BIOSCIENCES, INC.

Sign in to watch
Ticker
REVB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843898466
Phone
650-800-3717
Business address
4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA, 92122
Former names
Petra Acquisition Inc.

Securities

  • REVB Common Stock Nasdaq
  • REVBW Warrant Nasdaq
Filings Insiders Search text
All 390 Financials 130 Shareholder Meetings 22 Executive Compensation 120 Insider Trading 70 Beneficial Ownership Interest 48 Business Combinations 110 Public Offerings 82 Mutual Funds and ETFs 11 Others 40
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-05-11
  3. DEF 14A Proxy Proxy Statement 2026-02-17
  4. DEF 14A Proxy Proxy Statement 2025-11-10
  5. DEF 14A Proxy Proxy Statement 2025-09-22
  6. DEF 14A Proxy Proxy Statement 2025-06-09
  7. DEF 14A Proxy Proxy Statement 2024-12-16
  8. DEF 14A Proxy Proxy Statement 2024-04-16
  9. DEF 14A Proxy Proxy Statement 2023-12-22
  10. DEF 14A Proxy Proxy Statement 2023-05-05
  11. DEF 14A Proxy Proxy Statement 2022-12-30
  12. DEF 14A Proxy Proxy Statement 2021-09-21

Page 1 of 1 · 11 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…